Last update 07 Sep 2023
Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Public Company|
1983|
Maharashtra, India|
BOM: 524715

Overview

Tags

Skin and Musculoskeletal Diseases
Infectious Diseases
Endocrinology and Metabolic Disease
Small molecule drug
Biosimilar
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases27
Nervous System Diseases21
Neoplasms13
Immune System Diseases20
Hemic and Lymphatic Diseases14
Endocrinology and Metabolic Disease24
Top 5 Drug TypeCount
Small molecule drug72
Biosimilar7
Synthetic peptide4
Monoclonal antibody4
Colony-stimulating factors4
Top 5 TargetCount
GR(Glucocorticoid receptor)5
50S subunit(50S ribosomal subunit)3
CSF-3R(Colony stimulating factor 3 receptor)2
HMG-CoA reductase(HMG-CoA reductase)2
H1 receptor(Histamine H1 receptor)2

Pipeline

Pipeline Snapshot as of 24 Sep 2023

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
IND Approval
Phase 1 Clinical
4
8
Phase 2 Clinical
Phase 3 Clinical
4
72
Approved
Other
72
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Suprofen
( Prostaglandin synthases )
Dermatitis, Perioral
More
Approved
Levetiracetam
( SV2A )
Epilepsies, Partial
More
Approved
Loratadine
( H1 receptor )
Respiratory Hypersensitivity
More
Approved
Quinine Sulfate
Malaria, Falciparum
More
Approved
Latanoprost
( PTGFR )
Glaucoma, Open-Angle
More
Approved
Login to view more data

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.